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See related research by Schilder et al. http://www.ccforum.com/content/18/2/R78,
and related correspondence by Honore et al., http://www.ccforum.com/content/19/1/392.I read with interest the recent article by Schilder et al.
reporting that plasma levels and the biomarker value
of neutrophil gelatinase-associated lipocalin (NGAL)
in critically ill patients with acute kidney injury (AKI)
are not affected by continuous venovenous hemofiltra-
tion (CVVH) [1]. Recently, Honore et al. [2] commen-
ted on the data by Schilder et al., suggesting that
further studies are warranted to definitely assess the
membranes and the dialytic techniques that can re-
move NGAL from plasma and thus affect its accuracy
as a marker of AKI.
Our results in 31 patients on maintenance hemodialysis
(MHD), published in Critical Care as part of a study that
evaluated the effect of glomerular filtration rate impair-
ment on diagnostic performance of NGAL [3], appear
quite different from those found by Schilder et al. in
critically ill patients who received CVVH. Patients on
MHD received low-flux dialysis (23 treatments) with a
polysulfone membrane (F8; Fresenius, Bad Homburg,
Germany), or different high-flux membranes. High-flux
dialysis treatments were performed in 13 patients by
using a triacetate cellulose membrane with a surface of
1.9 m2 and an ultrafiltration rate (UFR) of 8474 mL/h
per 100 mm Hg (N190 FH; Nipro, Osaka, Japan). The
remaining eight treatments were performed as hemo-
diafiltration with a polyphenylene membrane with a
surface of 2.0 m2 and a UFR of 6800 mL/h per 100 mm
Hg (Phylther; Bellco, Mirandola, Italy) or as an acrylonitrilCorrespondence: carlo.donadio@med.unipi.it
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surface of 2.15 m2 and a UFR of 6500 mL/h per 100 mm
Hg (Nephral 500; Gambro, Lund, Sweden). Dialysis length
was 4.0 ± 0.2 h, and blood flow was 312 ± 43 mL/min.
Mean plasma concentrations of NGAL increased by
9.1 ± 24.4 % at the end of low-flux dialysis, indicating
that low-flux polysulfone did not remove NGAL
(Fig. 1). Treatments with high-flux membranes de-
creased plasma NGAL significantly (P < 0.0001). The
reduction ratio of NGAL was higher after hemodiafil-
tration (52.1 ± 26.7 %) than after high-flux dialysis
(26.6 ± 26.1 %, P = 0.053).
Schilder et al. performed CVVH treatments with a
triacetate membrane with a surface of 1.9 m2 (UF-205),
a UFR of 3700 mL/h per 100 mm Hg lower than that of
our triacetate membrane, and a lower sieving coeffi-
cient for middle molecules (0.81 versus 0.91 for myo-
globin). During treatments, the blood flow was kept at
180 mL/min and the substitution fluid at 2 L/h. These
differences can justify, at least in part, the lower re-
moval of NGAL found in patients with AKI than in pa-
tients on MHD.
Besides the chemical composition of the membrane,
different parameters of the dialysis session may influ-
ence the removal of NGAL. Therefore, further studies
are warranted to assess the membranes and the dialytic
techniques that can affect the accuracy of NGAL as a
marker of AKI.distributed under the terms of the Creative Commons Attribution 4.0
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Fig. 1 Effect of dialysis with low-flux (LF) or high-flux (HF) membranes
on plasma concentrations of neutrophil gelatinase-associated lipocalin
(NGAL) in 31 patients on maintenance hemodialysis
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AKI: Acute kidney injury; CVVH: Continuous venovenous hemofiltration;
MHD: Maintenance hemodialysis; NGAL: Neutrophil gelatinase-associated
lipocalin; UFR: Ultrafiltration rate.
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